Drug Shortage Report for M-M-R II

Last updated on 2020-03-21 History
Report ID 103430
Drug Identification Number 00466085
Brand name M-M-R II
Common or Proper name (measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 5000UNIT 1000UNIT 1000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 10X1DOSE VIAL
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-01-16
Actual start date 2020-01-17
Estimated end date 2020-03-27
Actual end date 2020-03-20
Shortage status Resolved
Updated date 2020-03-21
Company comments Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-03-21 English Compare
v6 2020-03-20 English Compare
v5 2020-01-18 English Compare
v4 2020-01-17 English Compare
v3 2020-01-17 English Compare
v2 2020-01-16 French Compare
v1 2020-01-16 English Compare